A longitudinal multiomics analysis of a patient with multiple myeloma who developed peripheral T cell lymphoma after treatment with anti-BCMA CAR T cells and a GPRC5D-directed bispecific antibody ...

It is also important to emphasize that the most characteristic cell of ATLL is observed in the peripheral blood smear, especially in leukemic cases ... test or the Kruskal-Wallis test with Dunn’s ...

4 Peripheral blood smears reveal the characteristic elongation and sickling ... can detect either iron deficiency anemia or iron overload in patients who require multiple blood transfusions. 3 ...

Although the cause of multiple myeloma is not known, research shows that genetic changes in the DNA of a single plasma cell ...

Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood cells that produce infection-fighting antibodies. Multiple myeloma is not hereditary, meaning it is not passed ...

Study reveals multiple high-risk genetic changes predict worse multiple myeloma outcomes across all treatments.

In spite of recent advances in the management of multiple myeloma, cure has been elusive, with efforts to improve long-term ...

After being diagnosed with multiple myeloma, Valarie Traynham turned her journey into a mission—raising awareness, educating ...

Follow along on our guide to Multiple Myeloma, a cancer of the bone marrow's infection-fighting plasma cells. As cancerous ...

Multiple myeloma is a kind of blood cancer that starts in plasma cells. Inside most of your bones is a soft, spongy tissue called bone marrow. Here, your body makes hundreds of thousands of red ...

Multiple myeloma arises from a type of white blood cell called a plasma cell. It develops when a normal plasma cell changes into a myeloma cell, which can multiply uncontrollably. Multiple myeloma ...

Here’s my take on myeloma-related studies that I’m excited about now and in the year ahead, with a focus on smoldering multiple myeloma (SMM), newly diagnosed disease, and first relapse.